Huajian Medical plans to issue shares worth approximately HK$3.142 billion to acquire a 20.31% stake in Guofu Quantum, further strengthening its strategic layout in the RWA and digital finance sectors.

B.news
02 Sep 2025 09:43:02 AM
Huajian Medical (01931) announced that on September 1, 2025, its wholly-owned subsidiary FinalTouch Ltd. entered into an agreement with the seller to acquire a total of approximately 1.848 billion shares of Guofu Quantum (00290).
Huajian Medical plans to issue shares worth approximately HK$3.142 billion to acquire a 20.31% stake in Guofu Quantum, further strengthening its strategic layout in the RWA and digital finance sectors.

According to the Zhitong Finance App, Huajian Medical (01931) announced that on September 1, 2025, its wholly-owned subsidiary, FinalTouch Ltd., entered into an agreement with the seller to acquire approximately 1.848 billion shares of Guofu Quantum (00290), representing approximately 20.31% of the target company's total issued share capital. The total transaction consideration is approximately HK$3.142 billion, which will be satisfied by Huajian Medical through the allotment and issuance of consideration shares under its general mandate at an issue price of HK$9.69 per share.

Public information indicates that the target group primarily engages in various financial and related businesses, including investment banking, securities brokerage, asset management, margin financing, money lending, debt and equity investments, and immigration consulting services. Furthermore, Guofu Quantum is actively pursuing an innovation-driven strategy, focusing on the quantum technology industry and striving to achieve multi-dimensional and cross-disciplinary exploration and application of quantum technology at the business level.

The acquisition of a 20.31% stake in the target group is a key step for Huajian Medical in furthering the implementation of its RWA (Real World Assets) exchange strategy and achieving ecosystem synergy. It holds significant industry integration and strategic capital value. Following the completion of the transaction, Huajian Medical and Guofu Quantum will collaborate comprehensively and deeply on the "on-chain finance" ecosystem, jointly promoting the innovative development and practical application of digital financial infrastructure.

The two parties will fully leverage their technological advantages, license resources, asset reserves, and channel networks to focus on building an efficient, compliant, and open one-stop on-chain asset issuance, trading, and management platform. This will help promote the digital transformation, fragmented allocation, and cross-border flow of traditional financial assets, further expanding the boundaries and efficiency of financial services.

RWA